表記の事件につき、その医師に治療を受けていたという方からコメントをいただきました。ご参考までに、ネットで拾ってきた「取り下げ理由」（英文）とSurgery誌掲載時のレジュメ（英文）を転記しておきます。関心のある方はご覧ください。慶応のウエマツミノルという先生が取り下げたようです。
This article has been retracted at the request of the Editors.
Reason: It has been called to our attention by one of the indentified authors, Dr. Minoru Uematsu of Keio University School of Medicine, that he did not contribute to this paper and was unaware of its submission. In addition, Dr. Uematsu informs us that the data appear to be an updated version without attribution to his presentation at the 22nd Annual San Antonio Breast Cancer Symposium December 8？, 1999 (previously published as an abstract (Breast Cancer Research and Treatment 1999; 57:108). Dr. Uematsu also states that the information contained in the SURGERY article is misleading and inaccurate in that the patients were treated with whole breast irradiation in addition to the accelerated partial breast irradiation, a fact that was not stated in the article. The Editors feel that this is a serious misrepresentation of the treatment method.
The Editors have contacted Kazuhiko Sato, M.D., Ph.D., who submitted the manuscript for publication and is its first author. Dr. Sato concedes and apologizes for (1) the listing of Dr. Uematsu as an author without his permission, (2) failing to provide the attribution to the original presentation and (3) omitting the crucial fact that conventional whole breast irradiation of 50 Gy was used as a further treatment of patients receiving the APBI.
With these facts in hand, it is regrettable but necessary that we retract this article in its entirety.
******
Surgery. 2006 May;139(5):617-23.
Efficacy of accelerated partial breast irradiation as a neoadjuvant treatment for patients with breast cancer: a pilot study.
• Sato K,
• Uematsu M,
• Saito T,
• Tsuda H,
• Takeuchi H,
• Shigekawa T,
• Hiraide H.
Department of Surgery I, Saitama Red Cross Hospital, Saitama, Japan. sato-k-a@pg8.so-net.ne.jp
BACKGROUND: Breast conserving treatment (BCT) consists of breast-conserving operation and followed by whole-breast irradiation (WBI). Accelerated partial breast irradiation (APBI) is being considered as a possible alternative to WBI. Neoadjuvant APBI might provide more benefit than postsurgical APBI because tumor downstaging will enhance the likelihood of BCT. METHODS: APBI was delivered as 50 Gy in 5 fractions over 5 days before operation for patients with breast cancer of 3 to 4 cm in diameter. Patients with tumors 3 cm or less were deemed to be candidates for breast-conserving operation. RESULTS: Between September 1998 and August 1999, 12 women were enrolled. The mean tumor diameter and volume were reduced from 3.4 to 1.8 cm (reduction rate: 47%) and from 8.1 to 2.2 cm3 (reduction rate: 71%), respectively. The mean pathologic tumor size was 1.5 cm, and a complete pathologic response was found in 1 patient (8%). All patients were eligible for breast-conserving operation. No ipsilateral breast recurrences have been observed to date. CONCLUSIONS: This is the first report of neoadjuvant APBI for relatively large breast cancers. Although the number of participants was small, these results would encourage the development of clinical trials exploring the efficacy of neoadjuvant APBI.
PMID: 16701093 [PubMed - indexed for MEDLINE]
